Innovative Drug Delivery Systems for Regenerative Medicine, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 222
Special Issue Editor
2. Department of Elaboration and Evaluation of Drugs, Faculty of Pharmaceutical and Biological Sciences, University of Nantes, 44000 Nantes, France
Interests: regenerative medicine; tissue engineering; drug delivery; controlled release; biomaterial; nanotechnology; innovative design and processing; pre-clinical studies; clinical studies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Regenerative medicine seeks to treat patients with dysfunctional tissue, and the development of innovative biomaterial-based technologies is the subject of intensive research addressing this issue. Regarding active compound delivery systems, the spatiotemporal control of the release profile represents a real challenge in terms of optimal activity, stability and safety and would offer personalized medicine. In response to these challenges, sophisticated delivery systems are emerging, and this Special Issue aims to review recent advances in this field.
Focusing on strategies for spatiotemporal control of drug delivery within scaffolds for tissue engineering, major mechanisms and critical factors affecting release profiles will be highlighted, as well as nanotechnologies and mathematical model contributions to these new therapeutic approaches.
This Special Issue aims to cover all the steps from bench to bedside, starting from basic principles underlaying the design of delivery vehicles up to regulatory frameworks governing clinical applications.
Dr. Elise Verron
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- regenerative medicine
- tissue engineering
- drug delivery
- controlled release
- biomaterial
- nanotechnology
- innovative design and processing
- pre-clinical studies
- clinical studies
Related Special Issue
- Innovative Drug Delivery Systems for Regenerative Medicine in Pharmaceutics (11 articles)
